A protein family under 'stress' - Serpin stability, folding and misfolding

Frontiers in Bioscience

Volumn 10, Issue 1, 2005, Pages 288-299

  Devlin, Glyn L ^a   Bottomley, Stephen P ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Conformational disease; Protein aggregation; Protein folding; Protein misfolding; Review; Serpin

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMER; SERINE PROTEINASE INHIBITOR;

AMINO ACID SEQUENCE; ARTICLE; BETA SHEET; DISULFIDE BOND; ENERGY; GENE MUTATION; GENETIC CODE; KINETICS; MOLECULAR DYNAMICS; POLYMERIZATION; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEIN STABILITY; PROTEIN STRUCTURE; STRESS; THERMAL ANALYSIS;

EID: 17544381846     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1528     Document Type: Article

References (106)

1. Potempa, J., E. Korzus and J. Travis: The serpin superfamily of proteinase inhibitors: structure, function, and regulation. J Biol Chem 269, 15957-15960 (1994)
2. Silverman, G. A., P. I. Bird, R. W. Carrell, F. C. Church, P. B. Coughlin, P. G. Gettins, J. A. Irving, D. A. Lomas, C. J. Luke, R. W. Moyer, P. A. Pemberton, E. Remold-O'Donnell, G. S. Salvesen, J. Travis and J. C. Whisstock: The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J Biol Chem 276, 33293-33296 (2001)
3. Irving, J. A., R. N. Pike, A. M. Lesk and J. C. Whisstock: Phylogeny of the serpin superfamily: Implications of patterns of amio acid conservation for structure and function. Genome Res 10, 1841-1860 (2000)
4. Irving, J. A., P. J. Steenbakkers, A. M. Lesk, H. J. Op den Camp, R. N. Pike and J. C. Whisstock: Serpins in prokaryotes. Mol Biol Evol 19, 1881-1890 (2002)
5. Irving, J. A., L. D. Cabrita, J. Rossjohn, R. N. Pike, S. P. Bottomley and J. C. Whisstock: The 1.5 a crystal structure of a prokaryote serpin. Controlling conformational change in a heated environment. Structure (Camb) 11, 387-397 (2003)
6. Clarke, E. P., G. A. Cates, E. H. Ball and B. D. Sanwal: A collagen-binding protein in the endoplasmic reticulum of myoblasts exhibits relationship with serine protease inhibitors. J Biol Chem 266, 17230-17235 (1991)
7. Olsson, S. E., V. Odlind and G. L. Hammond: Plasma levels of cortisol and corticosteroid binding globulin during use of Norplant-2 implants. Contraception 35, 353-361 (1987)
8. Schick, C., P. A. Pemberton, G. P. Shi, Y. Kamachi, S. Cataltepe, A. J. Bartuski, E. R. Gornstein, D. Bromme, H. A. Chapman and G. A. Silverman: Cross-class inhibition of the cysteine proteinases cathepsins K, L, and S by the serpin squamous cell carcinoma antigen 1: a kinetic analysis. Biochemistry 37, 5258-5266 (1998)
9. Stratikos, E. and P. G. Gettins: Formation of the covalent serpin-proteinase complex involves translocation of the proteinase by more than 70 A and full insertion of the reactive center loop into beta-sheet A. Proc Natl Acad Sci USA 96, 4808-4813 (1999)
10. Huntington, J. A., R. J. Read and R. W. Carrell: Structure of a serpin-protease complex shows inhibition by deformation. Nature 407, 923-926 (2000)
11. Tew, D. J. and S. P. Bottomley: Intrinsic fluorescence changes and rapid kinetics of proteinase deformation during serpin inhibition. FEBS Lett 494, 30-33. (2001)
12. Loebermann, H., R. Tokuoka, J. Deisenhofer and R. Huber: Human alpha 1-proteinase inhibitor. Crystal structure analysis of two crystal modifications, molecular model and preliminary analysis of the implications for function. J Mol Biol 177, 531-557 (1984)
13. Anfinsen, C. B: Principles that govern the folding of protein chains. Science 181, 223-230 (1973)
14. Pearce, M. C., H. Rubin and S. P. Bottomley: Conformational Change and Intermediatesin the Unfolding of {alpha} 1-Antichymotrypsin. J Biol Chem 275, 28513-28518 (2000)
15. James, E. L., J. C. Whisstock, M. G. Gore and S. P. Bottomley: Probing the unfolding pathway of antitrypsin. J Biol Chem 274, 9482-9488 (1999)
16. Dobson, M. K. M: The fundamentals of protein folding: bringing together theory and experiment. Curr Opin Struct Biol 9, 92-101 (1999)
17. Cabrita, L. D. and S. P. Bottomley: How do proteins avoid becoming too stable? Biophysical studies into metastable proteins. Eur Biophys J 33, 83-88 (2004)
18. Bullough, P. A., F. M. Hughson, J. J. Skehel and D. C. Wiley: Structure of influenza haemagglutinin at the pH of membrane fusion. Nature 371, 37-43 (1994)
19. Carr, C. M., C. Chaudhry and P. S. Kim: Influenza hemagglutinin is spring-loaded by a metastable native conformation. Proc Natl Acad Sci USA 94, 14306-14313 (1997)
20. Carr, C. M. and P. S. Kim: A spring-loaded mechanism for the conformational change of influenza hemagglutinin. Cell 73, 823-832 (1993)
21. Baker, D., J. L. Sohl and D. A. Agard: A protein-folding reaction under kinetic control. Nature 356, 263-265 (1992)
22. Strausberg, S., P. Alexander, L. Wang, F. Schwarz and P. Bryan: Catalysis of a protein folding reaction: thermodynamic and kinetic analysis of subtilisin BPN' interactions with its propeptide fragment. Biochemistry 32, 8112-8119 (1993)
23. Eder, J., M. Rheinnecker and A. R. Fersht: Folding of subtilisin BPN': characterization of a folding intermediate. Biochemistry 32, 18-26 (1993)
24. Sinclair, J. F., J. J. Waddle, E. F. Waddill and T. O. Baldwin: Purified native subunits of bacterial luciferase are active in the bioluminescence reaction but fail to assemble into the alpha beta structure. Biochemistry 32, 5036-5044 (1993)
25. Clark, A. C., J. F. Sinclair and T. O. Baldwin: Folding of bacterial luciferase involves a non-native heterodimeric intermediate in equilibrium with the native enzyme and the unfolded subunits. J Biol Chem 268, 10773-10779 (1993)
26. Huber, R. and R. W. Carrell: Implications of the three-dimensional structure of alpha 1-antitrypsin for structure and function of serpins. Biochemistry 28, 8951-8966 (1989)
27. Wright, H. T. and M. A. Blajchman: Proteolytically cleaved mutant antithrombin-Hamilton has high stability to denaturation characteristic of wild type inhibitor serpins. FEBS Lett 348, 14-16 (1994)
28. Yamasaki, M. A., Y. Mikami, M. B. Hirose: Loop-inserted and thermostabilized structure of P1-P1' cleaved ovalbumin mutatn R339T. J Mol Biol 315, 113-120 (2002)
29. Gettins, P. and B. Harten: Properties of thrombin- and elastase-modified human antithrombin III. Biochemistry 27, 3634-3639 (1988)
30. Pemberton, P. A., R. A. Harrison, P. J. Lachmann and R. W. Carrell: The structural basis for neutrophil inactivation of C1 inhibitor. Biochem J 258, 193-198 (1989)
31. Pemberton, P. A., P. E. Stein, M. B. Pepys, J. M. Potter and R. W. Carrell: Hormone binding globulins undergo serpin conformational change in inflammation. Nature 336, 257-258 (1988)
32. Carrell, R. W. and M. C. Owen: Plakalbumin, alpha 1-antitrypsin, antithrombin and the mechanism of inflammatory thrombosis. Nature 317, 730-732 (1985)
33. Bruch, M., V. Weiss and J. Engel: Plasma serine proteinase inhibitors (serpins) exhibit major conformational changes and a large increase in conformational stability upon cleavage at their reactive sites. J Biol Chem 263, 16626-16630 (1988)
34. Schulze, A. J., U. Baumann, S. Knof, E. Jaeger, R. Huber and C. B. Laurell: Structural transition of alpha 1-antitrypsin by a peptide sequentially similar to beta-strand s4A. Eur J Biochem 194, 51-56 (1990)
35. Sohl, J. L. J. and D. A. S. S. Agard: Unfolded conformations of alpha-lytic protease are more stable than its native state. Nature 395, 817-819 (1998)
36. Seo, E. J., H. Im, J. S. Maeng, K. E. Kim and M. H. Yu: Distribution of the native strain in human alpha 1-antitrypsin and its association with protease inhibitor function. J Biol Chem 275, 16904-16909 (2000)
37. Lee, K. N. P. and M. H. S. D. Yu: Probing the native strain in alpha 1-antitrypsin. Nat Struct Biol 3, 497-500 (1996)
38. Ryu, S. E., H. J. Choi, K. S. Kwon, K. N. Lee and M. H. Yu: The native strains in the hydrophobic core and flexible reactive loop of a serine protease inhibitor: crystal structure of an uncleaved alpha1-antitrypsin at 2.7 A. Structure 4, 1181-1192 (1996)
39. Im, H., E. J. Seo and M. H. Yu: Metastability in the inhibitory mechanism of human alphal-antitrypsin. J Biol Chem 274, 11072-11077 (1999)
40. Lee, C., J. S. Maeng, J. P. Kocher, B. Lee and M. H. Yu: Cavities of alpha(1)-antitrypsin that play structural and functional roles. Protein Sci 10, 1446-1453 (2001)
41. Lee, C., S. H. Park, M. Y. Lee and M. H. Yu: Regulation of protein function by native metastability. Proc Natl Acad Sci USA 97, 7727-7731 (2000)
42. Im, H., M. S. Woo, K. Y. Hwang and M. H. Yu: Interactions Causing the Kinetic Trap in Serpin Protein Folding. J Biol Chem 277, 46347-46354 (2002)
43. Dafforn, T. R., R. N. Pike and S. P. Bottomley: Physical characterization of serpin conformations. Methods 32, 150-158 (2004)
44. Hekman, C. M. and D. J. Loskutoff: Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants. J Biol Chem 260, 11581-11587 (1985)
45. Salonen, E. M., A. Vaheri, J. Pollanen, R. Stephens, P. Andreasen, M. Mayer, K. Dano, J. Gailit and E. Ruoslahti: Interaction of plasminogen activator inhibitor (PAI-1) with vitronectin. J Biol Chem 264, 6339-6343 (1989)
46. Wiman, B., A. Almquist, O. Sigurdardottir and T. Lindahl: Plasminogen activator inhibitor 1 (PAI) is bound to vitronectin in plasma. FEBS Lett 242, 125-128 (1988)
47. Declerck, P. J., M. De Mol, M. C. Alessi, S. Baudner, E. P. Paques, K. T. Preissner, G. Muller-Berghaus and D. Collen: Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma. Identification as a multimeric form of S protein (vitronectin). J Biol Chem 263, 15454-15461 (1988)
48. Mimuro, J. and D. J. Loskutoff: Purification of a protein from bovine plasma that binds to type 1 plasminogen activator inhibitor and prevents its interaction with extracellular matrix. Evidence that the protein is vitronectin. J Biol Chem 264, 936-939 (1989)
49. Mottonen, J., A. Strand, J. Symersky, R. M. Sweet, D. E. Danley, K. F. Geoghegan, R. D. Gerard and E. J. Goldsmith: Structural basis of latency in plasminogen activator inhibitor-1. Nature 355, 270-273 (1992)
50. Munch, M., C. Heegaard, P. H. Jensen and P. A. Andreasen: Type-1 inhibitor of plasminogen activators. Distinction between latent, activated and reactive centre-cleaved forms with thermal stability and monoclonal antibodies. FEBS Lett 295, 102-106 (1991)
51. Lomas, D. A., P. R. Elliott, W. S. Chang, M. R. Wardell and R. W. Carrell: Preparation and characterization of latent alpha 1-antitrypsin. Journal of Biological Chemistry 270, 5282-5288 (1995)
52. Chang, W. S. and D. A. Lomas: Latent alpha1-antichymotrypsin. A molecular explanation for the inactivation of alpha1-antichymotrypsin in chronic bronchitis and emphysema. J Biol Chem 273, 3695-3701 (1998)
53. Carrell, R. W., P. E. Stein, G. Fermi and M. R. Wardell: Biological implications of a 3 A structure of dimeric antithrombin. Structure 2, 257-270 (1994)
54. Wardell, M. R., J. P. Abrahams, D. Bruce, R. Skinner and A. G. Leslie: Crystallization and preliminary X-ray diffraction analysis of two conformations of intact human antithrombin. J Mol Biol 234, 1253-1258 (1993)
55. Gooptu, B., B. Hazes, W. S. Chang, T. R. Dafforn, R. W. Carrell, R. J. Read and D. A. Lomas: Inactive conformation of the serpin alpha(1)- antichymotrypsin indicates two-stage insertion of the reactive loop: Implications for inhibitory function and conformational disease. Proc Natl Acad Sci USA 97, 67-72 (2000)
56. Lomas, D. A. and R. Mahadeva: Alpha1-antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapy. J Clin Invest 110, 1585-1590 (2002)
57. Chow, M. K., D. A. Lomas and S. P. Bottomley: Promiscuous Beta-strand interactions and the conformational diseases. Curr Med Chem 11, 491-499 (2004)
58. Mast, A. E., J. J. Enghild and G. Salvesen: Conformation of the reactive site loop of alpha 1-proteinase inhibitor probed by limited proteolysis. Biochemistry 31, 2720-2728 (1992)
59. Koloczek, H., A. Banbula, G. S. Salvesen and J. Potempa: Serpin alpha 1proteinase inhibitor probed by intrinsic tryptophan fluorescence spectroscopy. Protein Science 5, 2226-2235 (1996)
60. Bottomley, S. P., P. C. Hopkins and J. C. Whisstock: Antitrypsin polymerisation can occur by both loop A and C sheet mechanisms. Biochem. Biophys Res Comm 251, 1-5 (1998)
61. Lomas, D. A., D. L. Evans, J. T. Finch and R. W. Carrell: The mechanism of Z alpha 1-antitrypsin accumulation in the liver. Nature 357, 605-607 (1992)
62. Sivasothy, P., T. R. Dafforn, P. G. Gettins and D. A. Lomas: Pathogenic alpha 1-antitrypsin polymers are formed by reactive loop-beta -sheet A linkage. J Biol Chem 275, 33663-33668 (2000)
63. Skinner, R., J. P. Abrahams, J. C. Whisstock, A. M. Lesk, R. W. Carrell and M. R. Wardell: The 2.6 Angstrom Structure Of Antithrombin Indicates a Conformational Change At the Heparin Binding Site. Journal of Molecular Biology 266, 601-609 (1997)
64. Lomas, D. A., P. R. Elliott, S. K. Sidhar, R. C. Foreman, J. T. Finch, D. W. Cox, J. C. Whisstock and R. W. Carrell: alpha 1-antitrypsin Mmalton (Phe52-deleted) forms loop-sheet polymers in vivo. Evidence for the C sheet mechanism of polymerization. Journal of Biological Chemistry 270, 16864-16870 (1995)
65. Wardell, M. R., W. S. Chang, D. Bruce, R. Skinner, A. M. Lesk and R. W. Carrell: Preparative induction and characterization of L-antithrombin: a structural homologue of latent plasminogen activator inhibitor-1. Biochemistry 36, 13133-13142 (1997)
66. Bottomley, S. P., P. C. Hopkins and J. C. Whisstock: Alpha1-antitrypsin polymerisation can occur by both loop A and C sheet mechanisms. Biochem Biophys Res Commun 251, 1-5 (1998)
67. Sharp, A. M., P. E. Stein, N. S. Pannu, R. W. Carrell, M. B. Berkenpas, D. Ginsburg, D. A. Lawrence and R. J. Read: The active conformation of plasminogen activator inhibitor 1, a target for drugs to control fibrinolysis and cell adhesion. Structure Fold Des 7, 111-118 (1999)
68. Zhou, A., R. Faint, P. Charlton, T. R. Dafforn, R. W. Carrell and D. A. Lomas: Polymerization of plasminogen activator inhibitor-1. J Biol Chem 276, 9115-9122 (2001)
69. Marszal, E., D. Danino and A. Shrake: A novel mode of polymerization of alpha1-proteinase inhibitor. J Biol Chem 278, 19611-19618 (2003)
70. Liu, T., P. A. Pemberton and A. D. Robertson: Three-state unfolding and self-association of maspin, a tumor-suppressing serpin. J Biol Chem 274, 29628-29632 (1999)
71. Onda, M., E. Tatsumi, N. Takahashi and M. Hirose: Refolding process of ovalbumin from urea-denatured state. Evidence for the involvement of nonproductive side chain interactions in an early intermediate. J Biol Chem 272, 3973-3979 (1997)
72. Tew, D. J. and S. P. Bottomley: Probing the Equilibrium Denaturation of the serpin alpha(1)-Antitrypsin with Single Tryptophan Mutants; Evidence for Structure in the Urea Unfolded State. J Mol Biol 313, 1161-1169 (2001)
73. Cabrita, L. D., J. C. Whisstock and S. P. Bottomley: Probing the Role of the F-Helix in Serpin Stability through a Single Tryptophan Substitution. Biochemistry 41, 4575-4581 (2002)
74. Pande, V. S., A. Grosberg, T. Tanaka and D. S. Rokhsar: Pathways for protein folding: is a new view needed? Curr Opin Struct Biol 8, 68-79 (1998)
75. Dill, K. C., HS: From Levinthal to pathways to funnels. Nat Struct Biol 4, 10-19 (1997)
76. Yu, M. H., K. N. Lee and J. Kim: The Z type variation of human alpha 1-antitrypsin causes a protein folding defect. Nature Structural Biology 2, 363-367 (1995)
77. Dafforn, T. R., R. Mahadeva, P. R. Elliott, P. Sivasothy and D. A. Lomas: A kinetic mechanism for the polymerization of alpha1-antitrypsin. J Biol Chem 274, 9548-9555 (1999)
78. Chow, M. K., G. L. Devlin and S. P. Bottomley: Osmolytes as modulators of conformational changes in serpins. Biol Chem 382, 1593-1599. (2001)
79. Devlin, G. L., H. Parfrey, D. J. Tew, D. A. Lomas and S. P. Bottomley: Prevention of polymerization of M and Z alpha1-Antitrypsin (alpha1-AT) with trimethylamine N-oxide. Implications for the treatment of alpha1-at deficiency. Am J Respir Cell Mol Biol 24, 727-732 (2001)
80. Wang, A. and D. W. Bolen: A naturally occurring protective system in urea-rich cells: mechanism of osmolyte protection of proteins against urea denaturation. Biochemistry 36, 9101-9108 (1997)
81. Zhou, A., P. E. Stein, J. A. Huntington and R. W. Carrell: Serpin polymerization is prevented by a hydrogen bond network that is centered on his-334 and stabilized by glycerol. J Biol Chem 278, 15116-15122 (2003)
82. Bottomley, S. P. and D. J. Tew: The citrate ion increases the conformational stability of alpha(1)-antitrypsin. Biochim Biophys Acta 1481, 11-17 (2000)
83. Devlin, G. L., M. K. Chow, G. J. Howlett and S. P. Bottomley: Acid Denaturation of alpha(1)-Antitrypsin: Characterization of a Novel Mechanism of Serpin Polymerization. J Mol Biol 324, 859-870 (2002)
84. Stein, P. E. and R. W. Carrell: What do dysfunctional serpins tell us about molecular mobility and disease? Nat Struct Biol 2, 96-113 (1995)
85. James, E. L. and S. P. Bottomley: The mechanism of alpha 1-antitrypsin polymerization probed by fluorescence spectroscopy. Arch Biochem Biophys 356, 296-300 (1998)
86. Crowther, D. C., L. C. Serpell, T. R. Dafforn, B. Gooptu and D. A. Lomas: Nucleation of alpha(1)-Antichymotrypsin Polymerization. Biochemistry 42, 2355-2363 (2003)
87. Devlin, G. L., J. A. Carver and S. P. Bottomley: The selective inhibition of serpin aggregation by the molecular chaperone, alpha-crystallin, indicates a nucleation-dependent specificity. J Biol Chem 278, 48644-48650 (2003)
88. Thakur, A. K. and R. Wetzel: Mutational analysis of the structural organization of polyglutamine aggregates. Proc Natl Acad Sci USA 99, 17014-17019 (2002)
89. Herve, M. and C. Ghelis: Conformational stability of the covalent complex between elastase and alpha 1-proteinase inhibitor. Arch Biochem Biophys 285, 142-146 (1991)
90. Powell, L. M. and R. H. Pain: Effects of glycosylation on the folding and stability of human, recombinant and cleaved alpha 1-antitrypsin. Journal of Molecular Biology 224, 241-252 (1992)
91. Lomas, D. A., J. T. Finch, K. Seyama, T. Nukiwa and R. W. Carrell: Alpha 1-antitrypsin Siiyama (Ser53 - >Phe). Further evidence for intracellular loop-sheet polymerization. Journal of Biological Chemistry 268, 15333-15335 (1993)
92. Mahadeva, R., T. R. Dafforn, R. W. Carrell and D. A. Lomas: 6-mer peptide selectively anneals to a pathogenic serpin conformation and blocks polymerization. Implications for the prevention of Z alpha(1)-antitrypsin- related cirrhosis. J Biol Chem 277, 6771-6774 (2002)
93. Lomas, D. A., D. L. Evans, S. R. Stone, W. S. Chang and R. W. Carrell: Effect of the Z mutation on the physical and inhibitory properties of alpha 1-antitrypsin. Biochemistry 32, 500-508 (1993)
94. Fitton, H. L. P., R. N. Carrell, W. S. R. W. Chang: Mechanisms of antithrombin polymerisation and heparin activation probed by the insertion of synthetic reactive loop peptides. Biol Chem 378, 1059-1063 (1997)
95. Eldering, E. V., E. Roem, D. Meo, M. T. Tosi: COOH-terminal sunstitutions in the serpin cl inhibitor tht cause loop overinsertion and subsequent multimerization. J Biol Chem 270, 2579-2587 (1995)
96. Chang, W. S. W., J. Whisstock, P. C. R. Hopkins, A. M. Lesk, R. W. Carrell and M. R. Wardell: Importance Of the Release Of Strand 1c to the Polymerization Mechanism Of Inhibitory Serpins. Protein Science 6, 89-98 (1997)
97. Matsunaga, E., S. Shiokawa, H. Nakamura, T. Maruyama, K. Tsuda and Y. Fukumaki: Molecular analysis of the gene of the alpha 1-antitrypsin deficiency variant, Mnichinan. Am J Hum Genet 46, 602-612 (1990)
98. Seyama, K., T. Nukiwa, K. Takabe, H. Takahashi, K. Miyake and S. Kira: Siiyama (serine 53 (TCC) to phenylalanine 53 (TTC)). A new alpha 1-antitrypsin-deficient variant with mutation on a predicted conserved residue of the serpin backbone. J Biol Chem 266, 12627-12632 (1991)
99. Poller, W., J. P. Faber, S. Weidinger, K. Tief, S. Scholz, M. Fischer, K. Olek, M. Kirchgesser and H. H. Heidtmann: A leucine-to-proline substitution causes a defective alpha 1-antichymotrypsin allele associated with familial obstructive lung disease. Genomics 17, 740-743 (1993)
100. Bruce, D., D. J. Perry, J. Y. Borg, R. W. Carrell and M. R. Wardell: Thromboembolic disease due to thermolabile conformational changes of antithrombin Rouen-VI (187 Asn - >Asp). J Clin Invest 94, 2265-2274 (1994)
101. Faber, J. P., W. Poller, K. Olek, U. Baumann, J. Carlson, B. Lindmark and S. Eriksson: The molecular basis of alpha 1-antichymotrypsin deficiency in a heterozygote with liver and lung disease. J Hepatol 18, 313-321 (1993)
102. Jeppsson, J. O: Amino acid substitution Glu leads to Lys alpha1-antitrypsin PiZ. FEBS Lett 65, 195-197 (1976)
103. Levy, N. J., N. Ramesh, M. Cicardi, R. A. Harrison and A. E. Davis 3rd: Type II hereditary angioneurotic edema that may result from a single nucleotide change in the codon for alanine-436 in the C1 inhibitor gene. Proc Natl Acad Sci USA 87, 265-268 (1990)
104. Aulak, K. S., E. Eldering, C. E. Hack, Y. P. T. Lubbers, R. A. Harrison, A. Mast, M. Cicardi and A. E. Davis: A Hinge Region Mutation In C1-Inhibitor (Ala(436)-]Thr) Results In Nonsubstrate-Like Behavior and In Polymerization Of the Molecule. J Biol Chem 268, 18088-18094 (1993)
105. Verpy, E., E. Couture-Tosi, E. Eldering, M. Lopez-Trascasa, P. Spath, T. Meo and M. Tosi: Crucial residues in the carboxy-terminal end of C1 inhibitor revealed by pathogenic mutants impaired in secretion or function. J Clin Invest 95, 350-359 (1995)
106. Kraulis, P. J: MOLSCRIPT: A Program to Produce Both Detailed and Schematic Plots of Protein Structures. J App Cryst 24, 946-950 (1991)